<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Diabetes and Obesity</title>
<title_fa></title_fa>
<short_title>Iran J Diabetes Obes.</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijdo.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6792</journal_id_issn>
<journal_id_issn_online>2345-2250</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1405</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>18</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Prevalence of Optimal HbA1c Levels in Type 2 Diabetes Mellitus Patients under Antidiabetic Treatment: A Cross-Sectional Study</title>
	<subject_fa>دیابت</subject_fa>
	<subject>Diabetes </subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Objective:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic disorder. Achieving stable, optimal HbA&lt;sub&gt;1C&lt;/sub&gt; levels is crucial for managing T2DM. The objective of our current study is to determine the prevalence of controlled HbA&lt;sub&gt;1C&lt;/sub&gt; levels among individuals who are diagnosed with T2DM and receiving antidiabetic medications.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Materials and Methods&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Adult patients with T2DM and under antidiabetic medications enrolled in our study. From March 2023 to February 2024, 196 patients were recruited in this study. Data on demographic and clinical information extracted from the patient&amp;#39;s records and HbA&lt;sub&gt;1C&lt;/sub&gt; levels were measured. The association between different factors and the achievement of optimal HbA&lt;sub&gt;1C&lt;/sub&gt; levels was evaluated among participants.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN&quot; style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Results:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Males achieved optimal HbA&lt;sub&gt;1c &lt;/sub&gt;levels more frequently than females (80.2% vs 78.5). Regarding the type of medication, participants with oral medications represented&lt;/span&gt;&lt;/span&gt;&lt;i&gt; &lt;/i&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;glycemic control 55%, compared to 45% in those receiving injectable drugs. Moreover, we observed an inverse association between the duration of diabetes onset and glycemic control status. Our study showed no significant differences in the prevalence of controlled HbA&lt;sub&gt;1C&lt;/sub&gt; levels based on age (&lt;i&gt;P&lt;/i&gt;= 0.087), gender (&lt;i&gt;P&lt;/i&gt;= 0.930), diabetes duration (&lt;i&gt;P&lt;/i&gt;= 0.660), and medication type (&lt;i&gt;P&lt;/i&gt;= 0.376).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;text-justify:inter-ideograph&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Conclusion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span style=&quot;font-size:10.5pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Most of the patients with T2DM who were receiving antidiabetic medications achieved optimal HbA&lt;sub&gt;1C &lt;/sub&gt;levels. It is recommended that additional education and support programs be provided to improve diabetes control and reduce its complications.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Diabetes mellitus, Glycated hemoglobin, Prevalence</keyword>
	<start_page>285</start_page>
	<end_page>293</end_page>
	<web_url>http://ijdo.ssu.ac.ir/browse.php?a_code=A-10-636-5&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Ghazal</first_name>
	<middle_name></middle_name>
	<last_name>Shahriari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0009-0001-0956-8829</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Student Research Committee, School of Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Paria </first_name>
	<middle_name></middle_name>
	<last_name>Babaahmadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0009-0003-1164-9243</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alireza</first_name>
	<middle_name></middle_name>
	<last_name>Arefzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0001-8484-3088 </orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Endocrinology, Farhikhtegan Hospital, Faculty of Medicine, Tehran Medical Sciences Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Shiehmorteza</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-8265-0554</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
